Peng Shu-Ling, Tsui Tung-Lin, Ting Ke-Hsin, Nassef Yasser, Lee Chia-Yi, Huang Jing-Yang, Yeh Chao-Bin, Weng Chia-Jui, Yang Shun-Fa
Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Division of Cardiology, Department of Internal Medicine, Camillian Saint Mary's Hospital Luodong, Luodong, Yilan, Taiwan.
Int J Med Sci. 2025 Feb 18;22(5):1176-1183. doi: 10.7150/ijms.108261. eCollection 2025.
Aortic stenosis (AS) is a fatal cardiovascular disease characterized by an inflammatory response. Blepharitis and hordeolum are two eyelid conditions that also involve ocular inflammation. The aim of this study is to assess the association between AS and the subsequent development of eyelid inflammatory diseases. This retrospective cohort study included individuals diagnosed with AS, who were matched to a control group of non-AS individuals from the TriNetX database. A total of 431,027 individuals were assigned to both the AS and non-AS groups. The primary outcomes of this study were the incidence rates of eyelid inflammatory diseases, including blepharitis and hordeolum. Cox proportional hazards regression was used for statistical analysis. After the follow-up period, 4,464 cases of blepharitis were recorded in the AS group, compared to 3,139 in the non-AS group. Additionally, there were 2,184 cases of hordeolum in the AS group, compared to 1,724 in the non-AS group. Cox proportional hazards regression analysis revealed that the AS group had a significantly higher risk of developing blepharitis (P < 0.001) and hordeolum (P < 0.001) compared to the non-AS group. The AS group also showed significantly higher cumulative probabilities of both blepharitis and hordeolum than the non-AS group (both P < 0.001). In subgroup analyses, AS patients exhibited a higher risk of developing blepharitis than the non-AS population, except for the Asian population and individuals aged 20-45 years. Similarly, the AS group showed a higher risk of developing hordeolum than the non-AS group, with exceptions in the African and Asian populations and individuals aged 20-45 years. In conclusion, the presence of AS is associated with a higher risk of developing subsequent eyelid inflammatory diseases.
主动脉瓣狭窄(AS)是一种以炎症反应为特征的致命性心血管疾病。睑缘炎和麦粒肿是两种同样涉及眼部炎症的眼睑病症。本研究的目的是评估AS与随后发生的眼睑炎性疾病之间的关联。这项回顾性队列研究纳入了被诊断为AS的个体,并与来自TriNetX数据库的非AS个体对照组进行匹配。共有431,027名个体被分配到AS组和非AS组。本研究的主要结局是眼睑炎性疾病的发病率,包括睑缘炎和麦粒肿。采用Cox比例风险回归进行统计分析。随访期结束后,AS组记录到4,464例睑缘炎病例,而非AS组为3,139例。此外,AS组有2,184例麦粒肿病例,非AS组为1,724例。Cox比例风险回归分析显示,与非AS组相比,AS组发生睑缘炎(P < 0.001)和麦粒肿(P < 0.001)的风险显著更高。AS组睑缘炎和麦粒肿的累积概率也显著高于非AS组(均P < 0.001)。在亚组分析中,除亚洲人群和20至45岁个体外,AS患者发生睑缘炎的风险高于非AS人群。同样,AS组发生麦粒肿的风险高于非AS组,非洲和亚洲人群以及20至45岁个体除外。总之,AS的存在与随后发生眼睑炎性疾病的较高风险相关。
Br J Ophthalmol. 2017-11-16
Ryoikibetsu Shokogun Shirizu. 1999
J Am Acad Dermatol. 2006-12
Diagnostics (Basel). 2024-6-25
Am J Cardiol. 2023-11-1
Eye Contact Lens. 2023-8-1
Postgrad Med J. 2023-7-21
Nat Rev Cardiol. 2023-8
Surg Clin North Am. 2022-6
Curr Opin Lipidol. 2021-12-1
Circ Res. 2021-4-30